Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial
Z Szarvas, Zeke Reyff, Anna Péterfi, Camila Bonin Pinto, Cameron D. Owens, Zalan Kaposzta, Péter Mukli, Ana Clara da C. Pinaffi‐Langley, Cheryl Adams, Mihaly Muranyi, Federico Silva Palacios, Beau Hawkins, Joseph A. Baur, Faddi G. Saleh Velez, Călin I. Prodan, Angelia Kirkpatrick, Anna Csiszár, Zoltán Ungvári, Priya Balasubramanian, Sharon Negri, Stefano Tarantini, Kai Ding, Alexander Buelow, Amir Akbari, J. Mikhail Kellawan, Andriy Yabluchanskiy
Topics & Concepts
NAD+ kinaseMedicineClinical trialPeripheralDiseasePharmacologyInternal medicineBiochemistryBiologyEnzymePeripheral Artery Disease ManagementStroke Rehabilitation and RecoveryCerebrovascular and Carotid Artery Diseases